FES PET changed nodal staging, field design and boost dose in ER-positive breast cancer
In a diagnostically difficult breast cancer case, FES PET identified occult ER-positive nodal disease and materially changed radiotherapy volume and dose.
Tag
pet-ct
Deep learning generated CT-free PET with near-zero SUV bias in NSCLC
Emission-only PET synthesis produced 0.72% SUVmax bias and 99.2% contrast recovery in an independent NSCLC test cohort.
Interim CT shrinkage and FDG-PET uptake predicted head and neck outcomes
Low CT tumour shrinkage strongly predicted poorer locoregional control, while high interim FDG-PET uptake predicted both poorer control and survival.
Metabolic tumour volume refined treatment selection in early NK/T-cell lymphom
An MTV threshold of 50 mL identified patients with poorer survival who appeared to benefit from combined-modality treatment.
In-beam PET enabled real-time radioactive ion beam range adaptation in mice
Radioactive carbon-11 beams enabled PET-guided range adjustment during irradiation, with biological outcomes matching insufficient, optimal and excessive beam penetration.